April 4, 2013—The Senate Judiciary Committee’s senior Republican has asked the Health Resources and Services Administration (HRSA) why it does not collect data on how much revenue safety-net providers derive from the 340B drug discount program, what is the payer mix for the 340B drugs they administer or dispense, and how they use 340B savings to meet program goals.
Sen. Charles Grassley (R-Iowa) gave HRSA until April 22 to respond to the request, which he made in a March 29 letter that his office released yesterday.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)